Packed with the latest campus headlines, @WashU is an e-newsletter distributed monthly to alumni, parents, and friends. Subscribe now to stay up-to-date on impactful research and events taking place across the university.
From the latest issue
Drug shows promise for ALS disease treatment
Long-term use of tofersen for people with rare genetic form of the illness slows symptom progression and leads to improvement in some.